Cargando…
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
Genome sequencing studies have shown that human malignancies often bear mutations in four or more driver genes(1), but it is difficult to recapitulate this degree of genetic complexity in mouse models using conventional breeding. Here we use the CRISPR-Cas9 system of genome editing(2–4) to overcome...
Autores principales: | Heckl, Dirk, Kowalczyk, Monika S., Yudovich, David, Belizaire, Roger, Puram, Rishi V., McConkey, Marie E., Thielke, Anne, Aster, Jon C., Regev, Aviv, Ebert, Benjamin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160386/ https://www.ncbi.nlm.nih.gov/pubmed/24952903 http://dx.doi.org/10.1038/nbt.2951 |
Ejemplares similares
-
High-performance CRISPR-Cas12a genome editing for combinatorial genetic screening
por: Gier, Rodrigo A., et al.
Publicado: (2020) -
CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020) -
Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells
por: Yudovich, David, et al.
Publicado: (2020) -
Orthologous CRISPR-Cas9 enzymes for Combinatorial Genetic Screens
por: Najm, Fadi J, et al.
Publicado: (2017) -
Application of CRISPR/Cas9 Tools for Genome Editing in the White-Rot Fungus Dichomitus squalens
por: Kowalczyk, Joanna E., et al.
Publicado: (2021)